The Barchart Chart of the Day belongs to the pharmaceutical preparations stock Eli Lilly (LLY). I found the stock by using Barchart to sort today's New 52 Week High list for the most frequent number of new highs in the last month, then again for technical buy signals of 80% or more. I always use the Flipchart feature to review the stocks for consistent price appreciation over the last 6 months. Since the Trend Spotter signaled a buy on 5/10 the stock gained 22.78%.
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
Barchart technical indicators:
- 96% technical buy signals
- 27.95+ Weighted Alpha
- 21.36% gain in the last year
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 16 new highs and up 15.95% in the last month
- Relative Strength Index 79.94%
- Technical support level at 98.31
- Recently traded at 99.55 with a 50 day moving average of 88.01
Fundamental factors:
- Market Cap $106 billion
- P/E 19.64
- Dividend yield 2.28%
- Revenue expected to grow 6.30% this year and another 2.00% next year
- Earnings estimated to increase 27.80% this year, an additional 4.90% next year and continue to compound at an annual rate of 12.10% for the next 5 years
- Wall Street analysts have 4 strong buy, 9 buy, 8 hold and 1 under perform recommendation in place on the stock.
